Literature DB >> 31764157

Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement on Perioperative Smoking Cessation.

Jean Wong1, Dong An, Richard D Urman, David O Warner, Hanne Tønnesen, Raviraj Raveendran, Hairil R Abdullah, Kurt Pfeifer, John Maa, Barry Finegan, Emily Li, Ashley Webb, Angela F Edwards, Paul Preston, Nathalie Bentov, Deborah C Richman, Frances Chung.   

Abstract

Smokers are at increased risk for surgical complications. Despite the known benefits of smoking cessation, many perioperative health care providers do not routinely provide smoking cessation interventions. The variation in delivery of perioperative smoking cessation interventions may be due to limited high-level evidence for whether smoking cessation interventions used in the general population are effective and feasible in the surgical population, as well as the challenges and barriers to implementation of interventions. Yet smoking is a potentially modifiable risk factor for improving short- and long-term patient outcomes. The purpose of the Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement on Perioperative Smoking Cessation is to present recommendations based on current scientific evidence in surgical patients. These statements address questions regarding the timing and intensity of interventions, roles of perioperative health care providers, and behavioral and pharmacological interventions. Barriers and strategies to overcome challenges surrounding implementation of interventions and future areas of research are identified. These statements are based on the current state of knowledge and its interpretation by a multidisciplinary group of experts at the time of publication.

Entities:  

Mesh:

Year:  2020        PMID: 31764157     DOI: 10.1213/ANE.0000000000004508

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  2 in total

1.  An Evaluation of Evidence Underpinning Management Recommendations in Tobacco Use Disorder Clinical Practice Guidelines.

Authors:  Sam Streck; Ryan McIntire; Lawrence Canale; J Michael Anderson; Micah Hartwell; Trevor Torgerson; Kelly Dunn; Matt Vassar
Journal:  Nicotine Tob Res       Date:  2022-04-28       Impact factor: 5.825

2.  Offering mailed nicotine replacement therapy and Quitline support before elective surgery: a randomised controlled trial.

Authors:  Ashley R Webb; Lisa Coward; Darshana Meanger; Samuel Leong; Sarah L White; Ron Borland
Journal:  Med J Aust       Date:  2022-03-10       Impact factor: 12.776

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.